Details for 2017700496
Up to date per 03.04.2026
Actions
Details for 2017700496
Granted/Registered
European Patent
14.11.2018 A
28.09.2022 B1
08.01.2016
EP
16150625
13.07.2016
EP
16179288
29.09.2016
EP
16191460
A61K 47/60 20170101AFI20170803BHEP
Owner
Ascendis Pharma Growth Disorders A/STuborg Boulevard 12 2900 HellerupDK
Representative
Representative
Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 91010 WienAT
Inventor
RAU, Harald 69120 HeidelbergDE
HERSEL, Ulrich 69120 HeidelbergDE
CLEEMANN, Felix 69120 HeidelbergDE
RASMUSSEN, Caroline, Elisabeth 2900 HellerupDK
Information about Fees